While compounds like angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, or β-blockers have been successfully used to treat the physiological symptoms of HF patients with reduced EF [62], little to no treatment is available for HF-induced mood and anxiety disorders. The gene discussed is NR3C2; the disease is anxiety disorder.